GlassScriptPhysician profile
Erica N Watson
NPI 1366097560
$1,908.29
in general payments reported to CMS, 2019-2025
19 companies · $39.71 in 2025
The $39.71 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,405 · 2022: $323 · 2023: $60.44 · 2024: $80.32 · 2025: $39.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $472.35 | 2021-2022 | |
| Abbvie INC. | $246.18 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $227.46 | 2021 | |
| Grt US Holding, INC. | $176.58 | 2021-2022 | |
| Vertos Medical, INC. | $147.54 | 2022 | |
| Collegium Pharmaceutical, INC. | $144.81 | 2021-2022 | |
| Nalu Medical, INC. | $135.79 | 2021 | |
| Lilly USA, LLC | $51.42 | 2021 | |
| Amgen INC. | $48.36 | 2021-2022 | |
| Allergan, INC. | $46.90 | 2021 | |
| Lundbeck LLC | $37.32 | 2021-2022 | |
| Ibsa Pharma INC. | $33.99 | 2021-2022 | |
| Eisai INC. | $32.22 | 2021 | |
| Scilex Pharmaceuticals INC. | $27.08 | 2022 | |
| Almatica Pharma LLC | $25.69 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $16.82 | 2021 | |
| Medtronic, INC. | $12.73 | 2021 | |
| Impel Pharmaceuticals INC. | $12.54 | 2022 | |
| Supernus Pharmaceuticals, INC. | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.